328130.KQ KOE
Lunit Inc.
1W: +7.8%
1M: +16.3%
3M: -5.4%
YTD: -75.0%
1Y: -76.6%
3Y: -88.2%
₩10,570.00 ($7.86)
-530.00 (-4.77%)
Weekly Expected Move ±15.7%
₩7251
₩8911
₩10570
₩12229
₩13889
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₩617.5B ($459.0M)
52W Range8180-24900
Volume563,147
Avg Volume583,228
Beta1.23
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOBeomseok Brandon Suh
Employees345
SectorHealthcare
IndustryMedical - Healthcare Information Services
IPO Date2022-07-21
Websitelunit.io
K-Square Gangnam 2
Seoul, SL
KR
Seoul, SL
KR
82 2 2138 0827
About Lunit Inc.
Lunit Inc., established in 2013 and headquartered in Seoul, South Korea, develops and supplies advanced artificial intelligence software solutions aimed at improving cancer screening, diagnosis, and treatment. The company's portfolio includes AI-powered tools for analyzing medical images like chest X-rays and mammograms, as well as intelligent biomarkers for immune phenotyping and precise PD-L1 quantification, which are vital for optimizing immunotherapy.
Latest News
No recent news
Recent Insider Trades
No insider trades found